Market Spotlight 2018: Opioid-Induced Constipation - 10-Year Disease Prevalence Forecast, and Licensing and Acquisition Deals - ResearchAndMarkets.com

DUBLIN--()--The "Market Spotlight: Opioid-Induced Constipation" report has been added to ResearchAndMarkets.com's offering.

This Market Spotlight report covers the Opioid-Induced Constipation market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals.

Key Takeaways

  • The approved drugs in the OIC space predominantly target opioid receptors, with the exception of Amitiza, a type-2 chloride channel activator. All of the marketed drugs are administered via the oral route, with one product also available in subcutaneous formulation.
  • The majority of industry-sponsored drugs in active clinical development for OIC are in Phase II, with only one drug in Phase III. Therapies in mid-to-late-stage development for OIC focus on targets such as opioid receptors and guanylyl cyclase c receptor. All of the pipeline drugs are administered via the oral route.
  • A Committee for Medicinal Products for Human Use (CHMP) opinion for Symproic is the only high-impact upcoming event in the OIC space.
  • There was only one licensing agreement involving OIC drugs during 2013-17.

Key Topics Covered:

KEY TAKEAWAYS

DISEASE BACKGROUND

TREATMENT

Management of OIC with laxatives

Management of OIC with opioid antagonists

Management of OIC with Amitiza, a secretagogue chloride channel activator

EPIDEMIOLOGY

Recent Prevalence Studies

Challenges

MARKETED DRUGS

PIPELINE DRUGS

KEY UPCOMING EVENTS

KEY REGULATORY EVENTS

Purdue Highlights Convenience Of New Opioid-Induced Constipation Drug Symproic

Valeant's Oral Relistor Poised To Face-Off Against AstraZeneca's Movantik

LICENSING AND ASSET ACQUISITION DEALS

PARENT PATENTS

REVENUE OPPORTUNITY

BIBLIOGRAPHY

Prescription Information

APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/zkdvt7/market_spotlight?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastroenterology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastroenterology